Anixa Biosciences is trading at $3.89 (+13.74%) in pre-market following a sharp overnight move with no fresh company-specific announcements identified.

  • The rally likely reflects broader biotech and risk sentiment as U.S. index futures trend higher, though the stock's gain significantly outpaces the broader market.
  • Analysts suggest the price action could be a result of low pre-market liquidity rather than a fundamental shift, especially given recent sector-wide weakness.